ResMed
464 hedge funds and large institutions have $9.58B invested in ResMed in 2018 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 171 increasing their positions, 150 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
464
Holders Change
+20
Holders Change %
+4.5%
% of All Funds
10.64%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
62
Increased
171
Reduced
150
Closed
38
Calls
$11M
Puts
$21M
Net Calls
-$10.1M
Net Calls Change
-$13.1M
Top Buyers
| 1 |
Los Angeles Capital Management
Los Angeles,
California
|
+$42.2M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$39.9M |
| 3 |
JPMorgan Chase & Co
New York
|
+$38.7M |
| 4 |
Morgan Stanley
New York
|
+$23.2M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$20.9M |
Top Sellers
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$61M |
| 2 |
BlackRock
New York
|
-$24.2M |
| 3 |
Goldman Sachs
New York
|
-$22M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$16.4M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$12.4M |
